The outlook revision reflects Moody’s Investors Service’s expectation that Lifespan will continue to improve its financial performance over the next several years.
Moody’s also affirmed the “Baa2” rating on Lifespan’s $300 million of debt and its “Baa2” issuer rating.
The rating affirmation is based on a number of factors, including Lifespan’s large size, leading market share and role as a provider of unique medical care and teaching services in the state.
More articles on healthcare finance:
This week’s 5 must-reads for hospital CFOs
CMS projects next decade of health expenditures, enrollment: 5 things to know
Kno2’s cloud fax technology coming to Aprima customers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
